Jefferies analyst Peter Misek is optimistic on the long-term commercial prospects of IBM's (NYSE: IBM) supercomputer Watson, although he is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE